ClinicalTrials.gg
RecruitingNCT04607538FKCUpdated Feb 17, 2023

The Faroese Knee Cohort: Etiology and Long-term Implications of Trochlear Dysplasia and Patellar Dislocations.

An observational study in Patellar Dislocation, ACL Injury and Meniscus Lesion, sponsored by Hvidovre University Hospital. Recruiting at 1 site in Denmark. Open to participants aged 15 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-17.

Sponsored by Hvidovre University Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Mar 2022; still recruiting 4 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
15 Years to 20 Years
Sex
All
01

Study summary

The investigators intend to establish a national cohort including all persons in the ages from 15-20 years old with patellar instability (PI) or a prior knee injury (ACL-ruptur or meniscus damage) . The cohort will be nicknamed "The Faroese Knee Cohort".

The overall aim is to investigate two groups.

  1. The patella instability group, in which we intend to investigate the following.

    • Prevalence of patellar dislocation and trochlear dysplasia in the Faroe Islands.
    • Risk factors for patellar dislocations-
    • Heredity of trochlear dysplasia.
    • If there is a specific gene responsible for the development of trochlear dysplasia.
    • The development of retropatellar artrhosis, its onset and its impact on quality of life and function,
  2. Knee injury group (ACL-ruptur or meniscus injury)

    • The prevalence of ACL-rupture and/or meniscus injury in this specific group in the Faroe Islands.
    • The impact on quality of life and function.
Read the detailed description

The Faroese Knee Cohort aims to consist of all persons in the Faroe Island between 15-20 years old with patellar instability* (PI) or a knee injury.

Special focus will be on PI, Patella dislocation (PD) and Trochlear Dysplasia (TD), a condition where the femoral trochlea has a dysplastic shape and lacks the lateral support of the patella. The diagnosis will be set by MRI of the knees and is in this study defined as the presence of one of the following: Crossing sign on a true lateral x-ray, lateral trochlear inclination angle \< 11 degrees or a trochlear depth \< 3 mm.

The hypothesis is that abnormal values in the following measures will be associated with increased risk of patellar dislocation and worse patient reported outcome: Caton-Deschamps index, Lateral Trochlear Inclination, Trochlear Facet Asymmetry, Trochlear Depth, Tuberostias Tibia - Trochlear Groove distance, Patello-trochlear index and Tuberositas Tibia - Posterior Cruciate Ligament distance.

Furthermore, we expect pivoting sports to be a behavioral risk factor.

The primary endpoint is measured by the number of patellar dislocations or near-dislocation the patient experiences (daily, weekly, monthly, yearly).

The secondary endpoint is the patient reported outcome measures.

*Definition: Patellar instability (PI) is the overall term encompassing both 1) recurrent patella dislocations and 2) recurrent episodes of a clear sensation of the kneecap riding on the outer border/aspect of the knee before popping back in track. The episodes must be a severe complaint for the patient. PI usually follows after a first time patellar dislocation.

02

Conditions studied

  • Patellar Dislocation
  • ACL Injury
  • Meniscus Lesion
  • Trochlear Dysplasia

Keywords

  • Patellar instability
  • Patellar dislocation
  • ACL-rupture
  • Meniscus lesion
  • Meniscus injury
03

In context

Patellar Dislocation

41 studies on the registry are indexed under Patellar Dislocation; 9 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 15 observational studies indexed under Patellar Dislocation.

Browse Patellar Dislocation studies →

Lead sponsor

Hvidovre University Hospital is the lead sponsor of 299 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All patients must either live or be born in the Faroe Islands, as this is a national cohort study. They will be invited to join the study if the live up to the inclusion criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 15-20 years at the start of patient enrolment.
  • The feeling of patellar instability, or patellar dislocation/near-dislocation.
  • The person has to be from the Faroe Islands.
  • All persons under the age of 18 must get written consent by their parents

Exclusion criteria

Exclusion Criteria:

  • Terminal illness
  • Mental disabilities and illness, meaning that the patient cannot independently answer the PROM´s and cooperate to the clinical investigation.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patellar dislocation, but no trochlear dysplasia

    This group consist of patients in age from 15-20 years old in the Faroe Islands, who experience patellar dislocation, but do not have femoral trochlear dysplasia measured on MRI or X-ray

    Other: No intervention is made

  • Patiens with patellar dislocation and trochlear dysplasia

    This group consists of patients in the age from 15-20 years old in the Faroe Islands, who have experience one or more patellar dislocations and have femoral trochlear dysplasia measured on MRI or X-ray

    Other: No intervention is made

  • Patients with other knee injury

    This group consists of patients in the age from 15-20 years old in the Faroe Islands, who have had an ACL-rupture or an meniscus injury.

    Other: No intervention is made

Interventions

  • OtherNo intervention is made

    No intervention is made. This i an observational study.

06

What researchers measure

Primary outcomes

  1. Severity of patellar dislocations

    The severity of PD defined by number of PD or near-dislocations the patient experience (daily, weekly, monthly, yearly).

    Time frame: 1 year

Secondary outcomes

  1. Risk factors for patellar dislocation 1

    The investigators will investigate if there is an correlation between the amount of patellar dislocations and the following measurements Caton-Deschamps index: Measuring in the ratio from 0-2. (normal 0.6-1.3, patella alta: \> 1.3, Patella Baja: \<0,6)

    Time frame: 1 year

  2. Risk factors for patellar dislocation 2

    The investigators will investigate if there is an correlation between the amount of patellar dislocations and the following measurements: Lateral Trochlear Inclination: Measured in degrees, the range from 0-20 degrees. (\< 11 degrees indicates trochlear dysplasia)

    Time frame: 1 year

  3. Risk factors for patellar dislocation 3

    The investigators will investigate if there is an correlation between the amount of patellar dislocations and the following measurements: Trochlear Facet Asymmetry: Measured in the ratio from 0-1. ( \< 0.4 indicates trochlear dysplasia)

    Time frame: 1 year

  4. Risk factors for patellar dislocation 4

    The investigators will investigate if there is an correlation between the amount of patellar dislocations and the following measurements: Trochlear Depth: Measured in centimeters in the range from 0-3 cm. (\< 3 cm is abnormal)

    Time frame: 1 year

  5. Risk factors for patellar dislocation 5

    The investigators will investigate if there is an correlation between the amount of patellar dislocations and the following measurements: Tuberositas Tibia - Trochlear Groove distance': Measured in mm, in the range from 0-25 mm (\< 15 mm is normal, 15-20 is borderline, \> 20 mm is abnormal)

    Time frame: 1 year

  6. Risk factors for patellar dislocation 6

    The investigators will investigate if there is an correlation between the amount of patellar dislocations and the following measurements: Patello-trochlear index: Is measured in a ratio in percentages. Measurements from 0-100%. (Normal range: 0.18-0.80, patella alta \< 0.18, patella baja \>0.80)

    Time frame: 1 year

  7. Patient reported activity

    The patient reported outcome measured by the following measurements: MARX score (Activity score),

    Time frame: 1 year

  8. Patient reported luxation score

    The patient reported outcome measured by the following measurements - Banff Patella Instability Instrument (Luxation score)

    Time frame: 1 year

  9. Patient reported patellofemoral pain

    The patient reported outcome measured by the following measurements * The Kujala score (Patellofemoral pain score)

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04607538
Responsible party
Kristoffer Barfod (MD. Ph.D. Associate Professor, Hvidovre University Hospital) — Principal investigator
First posted
Oct 29, 2020
Start date
Mar 1, 2022
Primary completion
Nov 1, 2024 (estimated)
Completion
Dec 1, 2051 (estimated)
Last update
Feb 17, 2023

Study contacts

Niclas Eysturoy, MD
Contact
nicey@ls.fo
+298 252629
Kristoffer Barfod, M.D. Ph.D.
Contact
kbarfod@dadlnet.dk
+ 45 61300288

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion